

BioTime is a biotechnology company focused on biomedical research and product development in regenerative medicine. Among its major competitors, BioTime is ranked in 10th place for NPS while GlaxoSmithKline is 1st, and Bristol Myers Squibb is 2nd.Their current market cap is $11.07M